Anixa Biosciences (ANIX) Financials

$2.83

$-0.07 (-2.41%)

As on 09-Sep-2026 16:26EDT

Market cap

$104 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Operating Revenue	--	--	--	0.21	2,469.00	0.51
Cost of Revenue	0.03	0.04	0.04	0.16	0.04	0.39
Gross Profit	-0.03	-0.04	-0.04	0.05	2,468.96	0.13
Operating Expenses	10.67	11.67	13.83	11.06	13.88	13.26
Operating Profit (EBIT)	-10.68	-11.70	-13.83	-11.01	-13.88	-13.14
Other Income	--	--	--	--	0.10	--
Profit before Tax	-10.12	-11.03	-12.70	-9.93	-13.77	-13.13
Provision for Tax	--	--	0.14	-0.12	-0.28	-0.18
Profit after Tax (Net Income)	-10.07	-10.93	-12.55	-9.81	-13.60	-12.95
Minority Interest	0.09	0.10	0.14	0.12	-0.18	0.17
Consolidated Profit	--	--	--	--	-13.60	-12.95

Liabilities ($ Mln)	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Shareholder's Funds	14.48	15.16	20.00	24.34	29.05	35.44
Minority Interest	0.09	--	--	--	-0.85	--
Non-Current Liabilities	0.14	0.16	0.20	0.12	0.18	0.22
Current Liabilities	1.50	1.97	2.50	2.03	2.04	1.27
Total Liabilities	16.37	16.08	21.59	25.52	30.41	36.26

Assets ($ Mln)	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Non-Current Assets	0.17	0.19	0.23	0.17	0.21	0.25
Current Assets	14.69	15.89	21.36	25.36	30.20	36.00
Total Assets	16.37	16.08	21.59	25.52	30.41	36.26
Total Debt*	0.18	0.20	0.23	0.18	0.22	0.26
Net Current Assets	13.19	13.92	18.86	23.33	28.16	34.73

Cashflow ($ Mln)	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Cash From Operating Activities	--	-7.17	-7.34	-6.21	-6.49	-4.94
Cash Flow from Investing Activities	--	4.87	4.28	-5.60	-10.73	-3.92
Cash from Financing Activities	--	2.28	3.42	0.37	0.45	31.57
Net Cash Inflow / Outflow	--	--	--	--	-16.77	--

Financials Ratios	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
ROCE (%)	--	-61.40	-56.12	-36.49	-41.85	-58.17
ROE (%)	-67.38	-62.16	-56.63	-36.76	-42.17	-58.58
ROA (%)	-57.19	-58.01	-53.29	-35.08	-40.78	-56.65
EBIT Margin (%)	--	--	--	-4,728.57	-0.56	-2,566.63
Net Margin (%)	--	--	--	-4,671.90	-0.55	-2,528.64
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Revenue Growth (%)	--	--	-1.00	-1.00	4,821.27	--
EBIT Growth (%)	38.09	13.15	-27.88	27.89	-4.79	-30.21
Net Profit Growth (%)	16.89	12.96	-27.96	27.83	-5.01	-27.77
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	7.15	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-8.76	1.36	1.56	2.39	2.15	2.71
Close Price ($)	3.00	4.13	3.50	3.16	5.60	4.77
High Price ($)	5.46	4.98	5.13	6.45	6.25	8.09
Low Price ($)	2.44	2.07	2.15	2.84	2.30	1.91
Market Cap ($ Cr)	104.45	--	--	--	--	--

Solvency Ratios	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Debt to Equity	--	0.01	0.01	0.01	0.01	0.01
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.00
Current Ratio	9.79	8.08	8.54	12.50	14.83	28.35
Quick Ratio	9.79	--	--	--	14.85	--
Interest Coverage	--	--	--	--	-132.41	-40,810.99

Operating Efficiency Ratios	TTM	Oct-25	Oct-24	Oct-23	Oct-22	Oct-21	Oct-20	Oct-19	Oct-18	Oct-17	Oct-16
Debtors to sales (%)	--	--	--	128.57	0.00	--
Asset Turnover	--	--	--	0.01	74.07	0.02
Receivable days	--	--	--	274.81	0.01	1.59
Inventory Days	--	--	--	-104.36	-400.04	-2,504.57
Payable days	--	3,500.31	3,608.08	534.26	1,743.63	174.74
Cash Conversion Cycle	--	--	--	-363.81	-2,143.66	-2,677.72

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.